Supply Chain Interruptions/ Recalls

Supply Chain Interruptions/ Recalls

Welcome to our dedicated page for Supply Chain Interruptions and Recalls in the dialysis industry. Here, you'll find the latest updates and critical information about disruptions and recalls affecting dialysis supplies and equipment. Our goal is to keep you informed and prepared, ensuring that you can manage your operations smoothly and maintain the highest standards of patient care despite unforeseen challenges. 

Last updated 9/9/24.

CLICK HERE TO SUBMIT UPDATES 

.

Drug Shortages/ Discontinuation

August 15: Alteplase Injection (Cathflo Activase) Shortage

  • Products affected
    • Cathflo Activase intravenous lyophilized powder for injection, Genentech, 2 mg, vial, 1 count, NDC 50242-0041-64
    • Cathflo Activase intravenous lyophilized powder for injection, Genentech, 2 mg, vial, 10 count, NDC 50242-0041-10

July 30: Hospira, Solu-cortef Injection 100mg vial (NDC 0009-0825-01) - Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: September 2024

July 17: Baxter Dubutamine available on allocation, previously in shortage

June 4: As part of Fresenius Medical Care North America’s (FMCNA) overall strategy to replace DELFLEX PVC with Biofine, we are temporarily discontinuing the DELFLEX 5L product in a PVC Container.

.

.

If you have information on a dialysis-related supply chain interruption, recall, correction, shortage, or discontinuation, please submit here.

If you have any questions, please contact marketing@renalhealthcare.org.

.